Author:
Gravett Andrew M.,Dalgleish Angus G.,Copier John
Funder
Institute for Cancer Vaccines and Immunotherapy
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Ashkenazi, A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2, 420–430 (2002).
2. Boldrini, L. et al. Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer. Int J Oncol 20, 155–159 (2002).
3. Wu, J. & Wood, G. S. Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma. Arch Dermatol 147, 443–449 (2011).
4. Hadji, A. et al. Death induced by CD95 or CD95 ligand elimination. Cell Rep 7, 208–222 (2014).
5. Peter, M. E. et al. The role of CD95 and CD95 ligand in cancer. Cell Death Differ 22, 885–886 (2015).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献